Escherichia coli ST131, an intriguing clonal group

MH Nicolas-Chanoine, X Bertrand… - Clinical microbiology …, 2014 - Am Soc Microbiol
In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

Aminoglycoside modifying enzymes

MS Ramirez, ME Tolmasky - Drug resistance updates, 2010 - Elsevier
Aminoglycosides have been an essential component of the armamentarium in the treatment
of life-threatening infections. Unfortunately, their efficacy has been reduced by the surge and …

The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones

U Naseer, A Sundsfjord - Microbial drug resistance, 2011 - liebertpub.com
The ongoing global spread and increased prevalence of CTX-M-type extended-spectrum β-
lactamases in Enterobacteriaceae is of great concern. The successful distribution of CTX-M …

Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective

CA Alonso, M Zarazaga, R Ben Sallem… - Letters in applied …, 2017 - academic.oup.com
In the last few years, different surveillances have been published in Africa, especially in
northern countries, regarding antimicrobial resistance among husbandry animals …

[HTML][HTML] High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso

AS Ouedraogo, M Sanou, A Kissou, S Sanou… - BMC infectious …, 2016 - Springer
Background Nothing is known about the epidemiology and resistance mechanisms of
extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso …

ESBL-producing Enterobacteriaceae in Africa – a non-systematic literature review of research published 2008–2012

V Storberg - Infection ecology & epidemiology, 2014 - Taylor & Francis
Introduction Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBL) has
been found all over the world, and risk factors for acquiring these bacteria involve hospital …

CTX-M-15-Producing Escherichia coli Clinical Isolates in Cairo (Egypt), Including Isolates of Clonal Complex ST10 and Clones ST131, ST73, and ST405 in Both …

N Fam, V Leflon-Guibout, S Fouad… - Microbial drug …, 2011 - liebertpub.com
In Egypt, little is known about the genetic background of Escherichia coli isolates harboring
extended-spectrum β-lactamase (ESBL). Five hundred twenty Enterobacteriaceae were …

[HTML][HTML] Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community

SF Ahmed, MMM Ali, ZK Mohamed, TA Moussa… - Annals of clinical …, 2014 - Springer
Background Extended-spectrum β-lactamases (ESBLs), including the AmpC type, are
important mechanisms of resistance among Enterobacteriaeceae. CTX-M type extended …

Review of Escherichia coli O157:H7 Prevalence, Pathogenicity, Heavy Metal and Antimicrobial Resistance, African Perspective

SM Gambushe, OT Zishiri… - Infection and Drug …, 2022 - Taylor & Francis
Escherichia coli O157: H7 is an important food-borne and water-borne pathogen that causes
hemorrhagic colitis and the hemolytic-uremic syndrome in humans and may cause serious …

Carbapenemases and extended-spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals

N Mathlouthi, C Al-Bayssari, A El Salabi… - The Journal of Infection …, 2016 - jidc.org
Introduction: The aim of the study was to investigate the prevalence of extended-spectrum β-
lactamase (ESBL) and carbapenemase production among clinical isolates of …